Status:
NOT_YET_RECRUITING
QOL After SURGERY and ADJUVANT Treatment
Lead Sponsor:
University of Salamanca
Conditions:
Carcinoma, Non-Small-Cell Lung
Quality of Life
Eligibility:
All Genders
50-85 years
Brief Summary
The goal of this prospective, observational study is to measure and analyze the effect of adjuvant treatment over the quality of life and recovery of patients undergoing pulmonary resection because of...
Detailed Description
Despite being surgery the preferred radical treatment of NSCLC in early stages, unforseen N2 disease, larger tumors or bad prognosis histological or molecular findings of the tumor will benefit of rec...
Eligibility Criteria
Inclusion
- Age: 50-85 years old
- Patients with any histological type of non-small-cell lung cancer in clinical stage T1C N0M0 or greater
- Patients that understand the purpose of the study, accept collaborate and sign the informed consent.
Exclusion
- Patients not receiving adjuvant treatment due to complications, bad quality of life or express rejection at any moment of the curse of the process.
- Patients who cannot complete the previous questionnaires to assess their quality of life
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06115239
Start Date
May 1 2024
End Date
January 1 2026
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico Universitario
Salamanca, Spain, 37007